Jennifer E. Cook, Director at Denali Therapeutics, holds 20.04K shares in Denali Therapeutics (Ticker: DNLI), holds 6.89K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 7.15K shares in BridgeBio Pharma (Ticker: BBIO).
What is the percentage of profitable transactions made by Jennifer E. Cook?
The percentage of profitable transactions made by Jennifer E. Cook is 80%.
What is the average return per transaction made by Jennifer E. Cook?
The average return per transaction made by Jennifer E. Cook is 9.20%.
What stocks does Jennifer E. Cook hold?
Jennifer E. Cook holds: DNLI, BBIO, JAZZ stocks.
What was Jennifer E. Cook’s latest transaction?
Jennifer E. Cook latest transaction was an Uninformative Sell of $31.68K.
What was Jennifer E. Cook's most profitable transaction?
Jennifer E. Cook’s most profitable transaction was an Informative Sell of JAZZ stock on August 15, 2023. The return on the trade was 23.70%.
What is Jennifer E. Cook's role in Denali Therapeutics?
Jennifer E. Cook's role in Denali Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.